格隆汇3月28日丨微泰医疗-B(02235.HK)发布公告,2024年,公司实现营业收入为人民币345.62百万元,同比增长36.5%。其中人民币180.43百万元来自持续葡萄糖监测系统的销售,该产品收入较截至2023年12月31日止年度的人民币75.71百万元增长138.3%。公司收入的显著增长主要归因于新一代持续葡萄糖监测系统的上市和商业化。报告期内,公司的毛利为人民币182.85百万元,较...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.